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Abstract
Glucose and fructose enter mammalian cells via facilitated diffusion, a process regulated by five glucose transporter
isoforms (GLUT1^5) at the plasma membrane. The tissue-specific pattern of GLUT isoform expression likely reflects
differing needs for glucose transport by various tissues. Myocytes must respond expeditiously to increased metabolic
demand. A basal isoform, GLUT1, and the insulin-regulatable glucose transporter, GLUT4, have been demonstrated in
human myocytes. GLUT3 has a high affinity for glucose, but its presence in human myocardium has not been clearly
established. The purpose of this study was to determine whether GLUT3 protein is present in human cardiac myocytes. We
examined rapidly frozen myocardial tissue from the explanted heart of seven patients undergoing cardiac transplantation,
from the heart of a young, previously healthy male organ donor, from the heart of a 67-year-old woman without known
cardiac disease who had a fatal stroke, and from the heart of six human fetuses. GLUT3 protein was detected by
immunoblots and localized by light and electron microscopy immunohistochemistry. The presence of GLUT3 protein was
verified in myocardial tissue by both immunoblots and immunohistochemistry. Light and electron microscopy confirmed
that GLUT3 was in cardiac myocytes. GLUT3 was also demonstrated as a 48 kDa protein in fetal myocardium, which was
present at 10 weeks, increased at 15 weeks, then decreased at 20 weeks of gestation. GLUT3 is present in human adult and
fetal myocardium. Human myocardial GLUT3 regulation and its role in myocardial glucose uptake remain to be
elucidated. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Glucose and fructose transport into mammalian
cells is facilitated by ¢ve functional GLUT isoforms,
GLUT1^5 [1^3]. Although the amino acid sequence
similarity among the isoforms is high, isoform ex-
pression is tissue- and species-speci¢c [1]. Two
GLUT isoforms, GLUT1 and GLUT4, have been
demonstrated in myocytes [4^6]. GLUT1 has a low
Km and provides many cells with their basal glucose
requirement whereas GLUT4 mediates insulin stimu-
lated glucose transport [7]. The tissue-speci¢c pattern
of GLUT expression likely re£ects di¡ering needs for
glucose transport by various tissues [2].
Myocytes must respond expeditiously to di¡ering
needs for glucose transport. Among GLUT isoforms,
GLUT3 has the lowest Km (1.4 mM for 2-deoxy-D-
glucose [8]). Whether GLUT3 is present in human
myocardium is not clear. One study reported
GLUT3 in human myocardium and another did
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not [9,10]. The human GLUT3 (hGLUT3) cDNA
was initially cloned using skeletal muscle from a
20^22-week-old fetus [11]. hGLUT3 is found pre-
dominantly in neural tissue, placenta and testes [3]
and has been described in platelets [12,13]. Because
of sequence di¡erences at the carboxy terminus of
the human and murine proteins [14], human and
murine antibodies which bind to the GLUT3 car-
boxy terminus do not cross-react [15]. In addition,
GLUT3 tissue distribution is di¡erent in humans and
mice [15]. In humans, hGLUT3 mRNA [11,16] has
been found in adult skeletal muscle. Despite the fact
that GLUT3 mRNA [17] and protein [18^22] were
detected in rat myoblasts and myotubes, GLUT3
mRNA was not present in monkey or rat skeletal
muscle [11] and GLUT3 protein was not present in
mouse skeletal muscle [15].
The purpose of this study was to determine
whether GLUT3 protein is present in human adult
and fetal myocardium and to examine whether it is
localized to myocytes.
2. Materials and methods
2.1. Patient population
The protocols to obtain tissue were approved by
the University of Iowa Human Subjects Committee.
2.1.1. Explanted hearts
Myocardial tissue was obtained as described below
from the explanted heart in seven adult cardiac
transplant recipients with cardiomyopathy, four
with coronary artery disease (ischemic cardiomyo-
pathy) and three without coronary artery disease (di-
lated cardiomyopathy). Myocardial tissue was simi-
larly obtained from an organ donor, a previously
healthy 12-year-old male. Following an accident, he
received several hours of intravenous medication for
blood pressure support and was subsequently de-
clared brain dead. Hemodynamic instability pre-
cluded adequate assessment of his heart for cardiac
transplantation. Myocardial tissue was obtained
from a 67-year-old woman without known cardiac
disease who had a fatal stroke. The heart was pre-
served on ice for approximately 8 h prior to obtain-
ing tissue samples.
2.1.2. Fetal tissue
Myocardial and skeletal muscle (gastrocnemius)
tissue was obtained as described below from six fe-
tuses of 10 to 21 weeks gestational age. Fetal ages
were estimated by a combination of gestational
dates, an estimate by the examining gynecologist,
and foot length [23].
2.2. Acquisition of myocardial tissue
Explanted hearts were obtained by one of the au-
thors (MGM) in the operating room as they were
excised. Myocardial tissue samples (at least 1 cm3)
were obtained immediately from the anterior left
ventricular wall. Tissue samples from the proximal
and distal portion of a given myocardial wall were
obtained in all hearts except the 12-year-old organ
donor in whom only a mid anterior wall sample was
obtained. The tissue was divided into epicardial and
endocardial samples, immediately frozen in liquid ni-
trogen, and stored at 370‡C until use. Separate sam-
ples for light and electron microscopy were obtained.
The fetal tissue was obtained and frozen in liquid
nitrogen by one of the authors (MGM) immediately
after elective abortion.
2.3. Quanti¢cation of GLUT3 protein
2.3.1. Tissue preparation
Using an a⁄nity puri¢ed rabbit polyclonal
hGLUT3 antibody, R1672, obtained from Dr.
Gwyn Gould [24], GLUT3 protein was assessed us-
ing a modi¢ed, previously published protocol which
investigated GLUT1 [25]. The tissue was placed in
cold TES bu¡er (10 mM Tris^HCl (pH 7.4), 250 mM
sucrose, 2 mM EDTA, 1.5 mM phenylmethylsulfo-
nyl£uoride), which included protease inhibitors, and
homogenized with a Tekmar Tissumizer (Cincinnati,
OH). Solubilized membrane proteins were prepared
by centrifugation in TES bu¡er. Protein was deter-
mined by the method of Bradford [26] using the Bio-
Rad protein assay (Hercules, CA).
2.3.2. Immunoblots
Samples were resolved on 10% SDS^polyacryl-
amide gel electrophoresis, and electrically transferred
to HyBond C membrane (Amersham, Arlington
Heights, IL). Immunoblots were developed by en-
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hanced chemiluminescence (ECL; Amersham).
Membranes were blocked by a 10 min incubation
in 10% non-fat dry milk in Tris-bu¡ered saline with
0.1% Tween-20 (TBS-T; pH 7.4), rinsed in TBS, in-
cubated with diluted primary antibody (rabbit anti-
human GLUT3 (1:500), anti-rat GLUT1 (5 Wg/ml),
or anti-rat GLUT4 (5 Wg/ml) for 1 h at room temper-
ature with agitation, rinsed twice with TBS-T for 10
min each time, incubated for 15 min with horseradish
peroxidase-linked secondary antibody anti-rabbit Ig
from donkey (1:1000; Amersham), and then rinsed
with TBS-T. Membranes were then incubated 1 min
with ECL detection solutions 1 and 2, and exposed
to autoradiography ¢lm (Hyper-¢lm MP, Amer-
sham) for approximately 5 s. The membranes were
stained with Ponceau-S to ascertain even protein
loading.
2.3.3. Peptide blocking
To investigate speci¢city of R1672 binding with
GLUT3, an immunoblot was incubated with both
GLUT3 peptide (50 Wg/ml; Alpha Diagnostic, San
Antonio, TX) and the primary antibody for 1 h.
All other procedures were as described above.
2.3.4. Cross-reactivity with actin
To determine hGLUT3 cross-reactivity with actin,
the following amounts of human brain and actin
protein were loaded onto two separate gels: 3, 10,
30, 100, 300 and 1000 ng. One immunoblot was in-
cubated with R1672 and the other with a rabbit anti-
actin antibody (10 Wg/ml; Sigma, St. Louis, MO) for
1 h. All other procedures were as described above.
2.3.5. Materials
The hGLUT3 antibody, R1672, an a⁄nity puri¢ed
rabbit polyclonal antibody, was kindly provided by
Dr. Gwyn Gould [9,24]. This antibody was made
against a peptide corresponding to the 14 COOH
terminal amino acids of hGLUT3 (NH2-MNSIEPA-
KETTNV-COOH). Antibodies to GLUT1 and
GLUT4 were purchased from Alpha Diagnostic
(San Antonio, TX). Rabbit actin was provided by
Dr. Larry Tobacman. Rabbit anti-actin antibody
and rabbit serum were obtained from Sigma. The
platelet-speci¢c antibody to glycoprotein IIIa,
CD61, was obtained from DAKO Corp. (Carpinte-
ria, CA).
2.4. Immunolocalization of GLUT3 protein
2.4.1. Light microscopy
Tissues were ¢xed in 10% bu¡ered formalin, then
embedded in para⁄n using routine procedures. Sec-
tions (6 Wm) were cut and mounted on Fisher Super-
frost Plus slides (Fisher Scienti¢c, Pittsburgh, PA)
and warmed at 45‡C until dry. Tissues were depar-
a⁄nized and rehydrated using routine procedures.
Immunogold labeling was performed as follows
(Aurion, Wageningen, Netherlands) [27,28]. Tissues
were blocked in 50 mM glycine in phosphate-bu¡-
ered saline (PBS; pH 7.4) for 30 min at room tem-
perature (RT) then in 5% acetylated bovine serum
albumin (BSA-C; Aurion) and 5% normal goat se-
rum (NGS) for 30 min at RT. Two washes followed,
5 min each, in incubation bu¡er (IB; 0.1% Aurion
BSA-C in PBS). Overnight incubation in GLUT3
primary antibody (R1672) diluted 1:500 in IB was
carried out at 4‡C. Tissues were then washed four
Fig. 1. Western blots from the anterior myocardial wall from a
previously normal 12-year-old boy. GLUT1 (top); GLUT4
(middle) ; hGLUT3 (bottom). Each control lane was loaded
with 10 Wg of protein and the lanes with myocardium were
loaded with 30 Wg of protein. Myocardial tissue was obtained
from the mid anterior wall and was divided into epicardial and
endocardial samples. GLUT1 lanes: 1, human brain; 2, carbo-
nate-treated rat skeletal muscle; 3, mid anterior wall epicardi-
um; 4, mid anterior wall endocardium. GLUT4 lanes: 1, carbo-
nate-treated rat skeletal muscle; 2, human brain; 3, mid
anterior wall epicardium; 4, mid anterior wall endocardium.
GLUT3 lanes: 1, human brain; 2, carbonate-treated rat skeletal
muscle; 3, rabbit actin; 4, mid anterior wall epicardium; 5, mid
anterior wall endocardium.
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times for 5 min each in IB. Incubation in a 1:75
dilution of secondary antibody consisting of goat
anti-rabbit IgG ultra small gold particles (0.8 nm)
in IB for 3 h at RT. Following this, tissues were
washed in IB four times for 5 min each, followed
by a 5-min wash in PBS, then ¢ve washes in deion-
ized water for 2 min each. Post-¢xation was in 2.5%
glutaraldehyde in PBS for 5 min, and ¢ve washes in
deionized water for 2 min each followed. Silver en-
hancement was performed by incubation with
Aurion R-Gent for 25 min at RT in the dark. Tissues
were rinsed in deionized water, counterstained with
hematoxylin^eosin, mounted in permount (Electron
Microscopy Sciences, Ft. Washington, PA), and
dried on a slide warmer for 24^48 h. Assessment of
non-speci¢c staining was accomplished using normal
rabbit serum instead of the GLUT3 antibody. Neg-
ative control tissues were immunostained as above,
but in normal rabbit serum instead of GLUT3 anti-
body.
Sections were viewed on a light microscope (Leitz
Diaplan; Leica, Wetzlar, Germany). Silver-enhanced
gold particles were visualized and photographed us-
ing an epi-polarization block. The silver-enhanced
gold particles depolarize and re£ect the polarized in-
cident light and show up as bright spots against a
dark background.
2.4.2. Transmission electron microscopy
For histology, tissues from explanted hearts were
¢xed in 2.5% glutaraldehyde in cacodylate bu¡er,
post¢xed in 1.0% bu¡ered osmium tetroxide contain-
ing 1.5% potassium ferrocyanide, then washed, dehy-
drated in acetone and embedded in Spur’s resin. Ul-
trathin sections were stained with uranyl acetate and
lead citrate.
For immunohistochemistry, tissues were minced
and ¢xed in 4% paraformaldehyde (Electron Micro-
scopy Sciences) in PBS (0.05 M), overnight at 4‡C.
Tissues were washed with PBS twice, then rinsed in
deionized water. Dehydration was carried out in 70%
ethanol (ETOH), two washes for 30 min each. Tis-
sues were incubated in (2:1) 70% ETOH and LR
White resin (Polysciences, Warrington, PA). In¢ltra-
tion with 100% LR White resin was carried out at
RT overnight. Two short washes with LR White
resin was followed by polymerization using thermal
curing at 65‡C for 24 h. Sections (100 nm) were
Fig. 2. Immunohistochemical localization of hGLUT3 using light microscopy in the distal anterior wall of a 67-year-old woman with-
out a history of heart disease. Myocytes and nuclei are delineated by hematoxylin^eosin stain (inset). The GLUT3 antibody is conju-
gated with silver-enhanced gold particles that depolarize and re£ect the polarized incident light and show up as bright spots against a
dark background. Presence of the bright spots within myocytes provides localization of hGLUT3. Bar = 10 Wm.
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collected on formvar-coated, 200-mesh nickel grids
(Electron Microscopy Sciences). Immunogold label-
ing was performed as above with the following ex-
ceptions. Blocking in 50 mM glycine in PBS was for
15 min. After blocking with 5% BSA and 5% NGS in
PBS, three washes in IB were performed. After over-
night incubation in GLUT3 primary antibody, six
washes in IB were performed. The dilution of the
secondary antibody, goat anti-rabbit IgG ultrasmall
gold particles (0.8 nm), was 1:40; subsequently six
washes in IB and three washes in PBS were per-
formed. After silver enhancement, ¢ve rinses in de-
ionized water were performed. Heavy metal staining
was performed in 5% uranyl acetate for 6 min fol-
lowed by three rinses for 1 min each in deionized
water. Sections were then counterstained in lead cit-
rate for 8 min and washed with 0.02 N NaOH six
times, 1 min each, then washed in deionized water six
times, 1 min each. Grids were allowed to air dry.
Sections were viewed using a Hitachi H7000 trans-
mission electron microscope (Tokyo, Japan).
Fig. 3. Immunohistochemical localization of hGLUT3 using electron microscopy in the epicardium of the anterior wall in the woman
without a history of cardiac disease. hGLUT3 localization. Ultrasmall gold conjugates are localized in myocytes. Particles are not
noted in the electron lucid area between myo¢bers. Membranes, including mitochondrial membranes, are not readily demonstrated
with paraformaldehyde ¢xation without osmium post¢xation. Extremely little non-speci¢c staining is present. Bar = 1 Wm.
Fig. 4. GLUT3 Western blot using fetal heart. All lanes were
loaded with 15 Wg of protein. Lanes: 1, human brain; 2, fetal
heart at 10 weeks gestation; 3, fetal heart at 15 weeks gesta-
tion; 4, fetal heart at 20 weeks gestation; 5, mid anterior wall
epicardium from the previously normal subject; 6, mid anterior
wall endocardium from the previously normal subject; 7, skele-
tal muscle at 15 weeks gestation; 8,9, skeletal muscle at 20
weeks gestation.
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Fig. 5. Immunohistochemical localization of hGLUT3 using light microscopy in fetal myocardium. Myocytes and nuclei are delineated
by hematoxylin and eosin stain (insets). Bar = 10 Wm. (A) Left ventricular myocardium from a 15-week-old fetus. hGLUT3 staining
was intense in myocytes of a 15-week-old fetus. Extremely little non-speci¢c staining is present. (B) Left ventricular myocardium from
a 21-week-old fetus. hGLUT3 staining was faint in myocytes of the 21-week-old fetus.
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2.4.3. Immunohistochemical identi¢cation of platelets
To determine the contribution of GLUT3 from
platelets in the myocardial tissue, immunohistochem-
istry was performed using the platelet-speci¢c anti-
body to glycoprotein IIIa, CD61 [29,30], and the
immunogold technique described above for light
and transmission electron microscopy. Platelets
were prepared using the following method. Whole
human blood was collected in a 7 ml vacutainer
tube without any anticoagulants. The blood was al-
lowed to clot on ice for 20 min. The clotted blood
was then ¢xed in 4% paraformaldehyde for electron
microscopy or 10% bu¡ered formalin for light micro-
scopy.
3. Results
3.1. Explanted hearts
3.1.1. Western blots
GLUT1 and GLUT4, and GLUT3 were present in
myocardium from a previously healthy 12-year-old
boy (Fig. 1). In patients with cardiomyopathy,
GLUT3 expression appeared to be less than in the
previously healthy boy. GLUT1 and GLUT4 expres-
sion appeared to be decreased in the endocardium
compared with the epicardium, which was more no-
ticeable in the distal wall samples and in patients
with ischemic cardiomyopathy (data not shown).
Speci¢city of the GLUT3 antibody was con¢rmed
by co-incubating human myocardial tissue with rab-
bit serum, which resulted in no binding on an immu-
noblot, and with the hGLUT3 peptide which resulted
in blocking all GLUT3 antibody binding on an im-
munoblot and by immunohistochemistry (data not
shown). Co-incubation of human myocardial tissue
with GLUT3 antibody and actin peptide resulted in
decreased actin binding. The higher speci¢city of
R1672 for GLUT3 than actin was con¢rmed when
R1672 detected brain GLUT3 in the 300 ng and 1000
ng protein samples whereas actin was not clearly
detectable in these samples. Anti-actin antibody de-
tected actin in the 300 ng and 1000 ng protein sam-
ples but did not detect GLUT3 (data not shown).
3.1.2. Immunohistochemistry
After incubation with hGLUT3 antibody, speci¢c
reaction product, indicating presence of hGLUT3,
was seen over myocytes both by light and electron
microscopy (Figs. 2 and 3). No reaction product was
observed in the absence of hGLUT3 antibody and in
the presence of rabbit serum (data not shown). By
electron microscopy, large, electron lucid spaces be-
tween myo¢bers contained very few gold particles.
These spaces were ¢lled with mitochondria when
conventional electron microscopy ¢xation and stain-
ing techniques were used (i.e., glutaraldehyde with
osmium post-¢xation).
Platelets were identi¢ed in blood using CD61 but
were extremely scarce in the myocardial tissue sam-
ple using electron microscopy (data not shown).
3.2. Fetal heart and skeletal muscle
3.2.1. Western blots
hGLUT3 was present in fetal heart at 10 weeks of
gestation (Fig. 4, lane 2), appeared to increase at 15
weeks (Fig. 4, lane 3), and to decrease at 20 weeks
(Fig. 4, lane 4). hGLUT3 was present in fetal skeletal
muscle at 15 and 20 weeks of gestation (Fig. 4, lanes
7^9).
3.2.2. Immunohistochemistry
hGLUT3 staining was intense in myocytes of the
15-week-old fetus (Fig. 5A) whereas only faint stain-
ing was present in myocytes of the 21-week-old fetus
(Fig. 5B).
4. Discussion
We have demonstrated the presence of GLUT3
protein in human adult and fetal myocardium and
in fetal skeletal muscle. Immunohistochemistry of
adult and fetal myocardium localized hGLUT3 with-
in myocytes.
Previously one group detected hGLUT3 in human
myocardium [9] and another did not [10]. One pos-
sible explanation for the disparate ¢ndings is that the
antibodies used for immunoblots were di¡erent. The
antibodies for human GLUT3 were made using a
peptide corresponding to the 14 [9] or 11 [10]
COOH-terminal amino acids. The GLUT3 antibody
we used does not recognize GLUT1, -2, ^4 or -5
proteins [9]. A second possible factor contributing
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to the contradictory ¢ndings regarding the presence
of GLUT3 is the length of time between death and
when the tissue was frozen. Haber et al. [10] acquired
human heart tissue less than 24 h after death, where-
as this information was not provided in the study by
Shepherd et al. [9]. In our study, we sought to min-
imize protein degradation, so tissue was obtained
and frozen in the operating room immediately as
the heart was explanted. A third possible factor is
that hGLUT3 expression is di¡erentially regulated
in cardiac disease. Preliminary data from our labo-
ratory suggest that hGLUT3 expression may be less
in hearts of patients with cardiomyopathy than in
hearts of people without known heart disease.
We demonstrated that the hGLUT3 protein is ap-
proximately 48 kDa, as previously described [9,10].
We observed di¡erent migration of brain and myo-
cardial hGLUT3 on the polyacrylamide gel, a ¢nding
likely due to di¡erential glycosylation. In addition to
the di¡erent molecular masses on immunoblots of
GLUT3 and actin, we demonstrated that the a⁄nity
of R1672 was much greater for GLUT3 than for
actin. Because platelets contain GLUT3 [12,13], we
performed immunohistochemistry, demonstrating
that the contribution of GLUT3 from platelets in
human myocardium is extremely small. Therefore,
our immunohistochemistry data con¢rm the presence
of GLUT3 in human myocardium.
The presence of hGLUT3 in human but not ro-
dent myocardium implies that it may not be possible
to use murine models to investigate the role of the
di¡erent GLUT isoforms on glucose metabolism in
human myocardial disease. An animal with myocar-
dial GLUT3 must be identi¢ed to conduct such stud-
ies.
Thus, human myocardium contains GLUT1,
GLUT4, and GLUT3. The relative expression of
GLUT isoforms in myocardial health and disease
remains to be investigated. A caveat regarding inter-
pretation of GLUT myocardial Western blots is that
they will include some GLUT1 from red blood cells
since red blood cells contain GLUT1 [31]. A prelimi-
nary report from Schwaiger et al. [32], using reverse
transcriptase PCR in myocardial biopsies from pa-
tients with ischemic heart disease, described an in-
crease in the ratio of GLUT1 and GLUT3 to
GLUT4 mRNA, but no data are currently available
regarding GLUT proteins.
The cell surface GLUT isoforms facilitate glucose
entry into the cell. GLUT3 has been observed in the
plasma membrane [19,33], and transports glucose
into cells with high a⁄nity [8,34]. GLUT3 protein
was located intracellularly in myoblasts but also ap-
peared on the plasma membrane in myotubes [19].
Translocation of GLUT3 (as well as GLUT1 and
GLUT4) proteins from the light microsome fraction
(i.e., intracellular) to the plasma membrane fraction
occurred in L6 myotubes exposed to insulin, IGF-I
and acylation-stimulating protein [18,20,22].
Glucose is critical for myocyte survival. Under
normal conditions, myocytes can utilize multiple
metabolic substrates. During ischemia and hypoxia,
myocytes utilize relatively more glucose via anaero-
bic glycolysis because of the inability to metabolize
fatty acids via L-oxidation [35,36]. Cellular availabil-
ity of glucose is also important for maintenance of
normal cellular integrity. Glycolysis not only prefer-
entially inhibits ATP-sensitive potassium channels
[37] but also is necessary to preserve myocardial cal-
cium homeostasis during L-adrenergic stimulation
[38]. Ischemic contracture begins when anaerobic gly-
colysis stops [39]. In addition, functional compart-
mentation of glycolytic versus oxidative metabolism
has been demonstrated [40]. For these reasons, my-
ocytes with impaired ability to take up glucose are at
increased risk of cell death. Understanding regula-
tion of myocardial GLUTs in order to maintain or
enhance glucose uptake may help prevent cell death.
Given the low Km of GLUT3 protein, an increase in
GLUT3 expression relative to expression of GLUT1
and GLUT4 may enable increased glucose entry into
myocytes during conditions of increased demand for
glucose. The regulation of human myocardial
GLUT3 and its role in myocardial glucose transport
remain to be elucidated.
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